Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICU | US
-0.12
-2.87%
Healthcare
Biotechnology
30/06/2024
09/04/2026
4.06
4.18
4.28
4.02
SeaStar Medical Holding Corporation a medical device company develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver Colorado.
View LessLow Debt to Equity (< 0.25)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
217.2%1 month
160.5%3 months
121.5%6 months
112.0%-
-
-
-0.46
0.91
-8.13
-
-
-
17.02M
17.02M
-
-
-
-
-
3.59
5.29
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.55
Range1M
2.86
Range3M
2.86
Rel. volume
0.30
Price X volume
290.71K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| PLUR | PLUR | Biotechnology | 3.39 | 18.54M | 0.89% | n/a | 30845.83% |
| Enveric Biosciences Inc | ENVB | Biotechnology | 2.04 | 18.20M | 4.08% | n/a | 0.00% |
| Cingulate Inc. Common Stock | CING | Biotechnology | 5.96 | 18.14M | 1.88% | n/a | 10.72% |
| DOMH | DOMH | Biotechnology | 2.88 | 18.08M | 0.00% | n/a | 7.66% |
| Can-Fite BioPharma Ltd | CANF | Biotechnology | 2.93 | 17.86M | -4.87% | n/a | 0.00% |
| Cue Biopharma Inc | CUE | Biotechnology | 0.2929 | 17.63M | 6.98% | n/a | 52.09% |
| Inhibikase Therapeutics Inc. | IKT | Biotechnology | 1.69 | 16.86M | -2.87% | n/a | 3.49% |
| Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 1.11 | 15.94M | -1.77% | n/a | 11.72% |
| DarT Bioscience Inc | DARE | Biotechnology | 1.85 | 15.81M | 0.00% | 0.12 | 218.34% |
| Aytu BioScience Inc | AYTU | Biotechnology | 2.56 | 15.74M | -3.76% | n/a | 54.59% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.16 | 16.95M | -4.13% | 0.03 | 16.03% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 11.02 | 16.78M | 94.36% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.651 | 12.58M | -0.82% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3 | 3.32M | 2.85% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2987 | 2.84M | 10.96% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.95 | 1.07M | -3.47% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.13 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 121.50 | - | Riskier |
| Debt to Equity | -0.46 | -1.23 | Expensive |
| Debt to Assets | 0.91 | 0.25 | Expensive |
| Market Cap | 17.02M | - | Emerging |